T 2731/17 (Antibody expression in myeloid leukaemia cells/GLYCOTOPE) of 11.12.2020
- European Case Law Identifier
- ECLI:EP:BA:2020:T273117.20201211
- Date of decision
- 11 December 2020
- Case number
- T 2731/17
- Online on
- 29 June 2021
- Petition for review of
- -
- Application number
- 07818090.8
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Use of human cells of myeloid leukaemia origin for expression of antibodies
- Applicant name
- Glycotope GmbH
- Opponent name
- Laboratoire Français du Fractionnement et des
Biotechnologies - Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 123(2)European Patent Convention Art 56
- Keywords
- Main request and auxilary request 1: amendments - allowable (no)
Auxiliary request 2: amendments - allowable (yes)
Auxiliary request 2: inventive step (yes) - Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the opposition division with the order to maintain the patent with the following claims and a description to be adapted thereto:
- Claims 1 to 47 of auxiliary request 2 filed with the statement of grounds of appeal.